Add Company
Join Now

ZEUS Scientific Revenue and Competitors

License our Company Data API

Branchburg, NJ USA

Location

N/A

Total Funding

Hospital/Healthcare

Industry

Estimated Revenue & Valuation

  • ZEUS Scientific's estimated annual revenue is currently $15.8M per year.(i)
  • ZEUS Scientific's estimated revenue per employee is $405,000

Employee Data

  • ZEUS Scientific has 39 Employees.(i)
  • ZEUS Scientific grew their employee count by -22% last year.

ZEUS Scientific's People

NameTitleEmail/Phone
1
Chief Scientific OfficerReveal Email/Phone
2
Director Quality AssuranceReveal Email/Phone
3
Director Research and DevelopmentReveal Email/Phone
4
Regional Account ManagerReveal Email/Phone
5
Regional Account ManagerReveal Email/Phone
6
ELISA Production ManagerReveal Email/Phone
7
Diagnostic Sales ManagerReveal Email/Phone
8
Regulatory Affairs SpecialistReveal Email/Phone
9
Financial ControllerReveal Email/Phone
10
Technical Services SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M5025%N/AN/A
#2
$275.2M72828%N/AN/A
#3
$35.9M1096%N/AN/A
#4
$11050M288364%$48.1MN/A
#5
$18.2M7521%N/AN/A
#6
$17M6826%N/AN/A
#7
$25.1M731%N/AN/A
#8
$24M8910%N/AN/A
#9
$17M6215%N/AN/A
#10
$9.7M34-3%N/AN/A
Add Company

What Is ZEUS Scientific?

ZEUS Scientific is your first choice for high-performing, easy-to-use clinical diagnostic solutions. Our products are designed and manufactured to ensure optimal efficiency and accurate diagnosis to facilitate better patient care. We offer a wide range of test systems across our core diagnostic areas of autoimmune and infectious disease serology, and are now expanding our menu to include unique predictive cardiac biomarkers and other novel diagnostic tools. The first predictive cardiac biomarker now available from ZEUS is AccuCardia (www.accucardia.com). Numerous scientific studies have established that the enzyme secreted phospholipase A2-IIA (sPLA2-IIA) is an emerging biomarker that plays an important role in inflammation and atherosclerosis. Now sPLA2-IIA can be quickly, easily, and accurately measured from human plasma. It is an advanced, proprietary system that is making cardiovascular risk assessment possible independently from conventional risk markers. Test with confidence. Test with ZEUS.

keywords:N/A

N/A

Total Funding

39

Number of Employees

$15.8M

Revenue (est)

-22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.4M398%N/A
#2
$11.4M4231%N/A
#3
$9M4522%N/A
#4
$6M49-17%N/A
#5
$7.5M5014%N/A